Bladder Cancer - Results from #40

Minimal Patient-Reported Side Effects for a Chemoablative Gel (UGN-102) Used as Frontline Treatment in Adults with Non-Muscle-Invasive Bladder Cancer. June 2, 2022

Energy source comparison in en-bloc resection of bladder tumors: subanalysis of a single-center prospective randomized study. June 2, 2022

CD24: A Marker for an Extended Expansion Potential of Urothelial Cancer Cell Organoids In Vitro? June 1, 2022

Single-Cell Analyses of a Novel Mouse Urothelial Carcinoma Model Reveal a Role of Tumor-Associated Macrophages in Response to Anti-PD-1 Therapy. June 1, 2022

Wnt/β-Catenin Signalling and Its Cofactor BCL9L Have an Oncogenic Effect in Bladder Cancer Cells. May 31, 2022

Optimization of Preoperative Lymph Node Staging in Patients with Muscle-Invasive Bladder Cancer Using Radiomics on Computed Tomography. May 31, 2022

Chronic kidney disease and radical cystectomy for bladder cancer: perioperative and oncologic outcomes in 1,214 patients. May 31, 2022

Characterizing molecular subtypes of high-risk non-muscle-invasive bladder cancer in African American patients. May 30, 2022

En Bloc Versus Conventional Transurethral Resection of Bladder Tumors: A Single-center Prospective Randomized Noninferiority Trial. May 30, 2022

Uroplakin II as a single marker for luminal versus basal molecular subtypes in muscle invasive urothelial carcinoma. May 27, 2022

Metformin exerts an antitumor effect by inhibiting bladder cancer cell migration and growth, and promoting apoptosis through the PI3K/AKT/mTOR pathway. May 27, 2022

Targeting FGFR3 alterations with adjuvant infigratinib in invasive urothelial carcinoma: the phase III PROOF 302 trial. May 26, 2022

Comparing Long-Term Survival Outcomes for Muscle-Invasive Bladder Cancer Patients Who Underwent with Radical Cystectomy and Bladder-Sparing Trimodality Therapy: A Multicentre Cohort Analysis. May 26, 2022

The Bladder Cancer Advocacy Network Announces Four Awardees of Its 2022 Young Investigator Awards May 26, 2022

Natural killer cells: unlocking new treatments for bladder cancer. May 25, 2022

Robot-Assisted, Laparoscopic, and Open Radical Cystectomy: Pre-Operative Data of 1400 Patients From The Italian Radical Cystectomy Registry. May 25, 2022

Quality of life and secondary outcomes for open versus robot-assisted radical cystectomy: a double-blinded, randomised feasibility trial. May 24, 2022

Real-world treatment patterns and clinical outcomes of Japanese patients with non-muscle invasive bladder cancer receiving intravesical bacillus Calmette-Guérin treatment. May 24, 2022

Early-stage multi-cancer detection using an extracellular vesicle protein-based blood test. May 24, 2022

Survival after Neoadjuvant/Induction Combination Immunotherapy versus Combination Platinum-based Chemotherapy for Locally Advanced (Stage III) Urothelial Cancer. May 24, 2022

Page 3 of 431

email news signup